510(k) · Cleared
ClearedVisia Dynamic Review
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
MeVis Medical Solutions AG · LNH System, Nuclear Magnetic Resonance Imaging
Cleared on Dec 30, 2011 after a 46-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below).
- Decided
- Dec 30, 2011
- Review
- 46 days
- Class
- Class II
- Product code
- LNH
- Recalls
- None
- Predicates
- 1
The summary cites one number, which could not be confirmed as its predicate (see the table below).
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LNH device
- #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.
| Type | Number | Device | Decided |
|---|---|---|---|
| Kept off the family tree | K03003 | Syngo BreVis Number could not be read |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All LNH devicesLNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.
FDA decisions per year · LNH
26in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LNH
122in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LNH
8in 2025
Class I (8 since 2007) Class II/III not classified
Adverse event reports per year · LNH
1,263in 2025
MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 12 | 35 | 25 | 114 |
| 2008 | 19 | 53 | 12 | 167 |
| 2009 | 17 | 70 | 7 | 194 |
| 2010 | 12 | 94 | 17 | 165 |
| 2011 | 16 | 81 | 11 | 182 |
| 2012 | 22 | 89 | 5 | 170 |
| 2013 | 19 | 108 | 2 | 107 |
| 2014 | 17 | 108 | 13 | 119 |
| 2015 | 19 | 140 | 12 (2) | 113 |
| 2016 | 20 | 108 | 1 | 135 |
| 2017 | 18 | 98 | 0 | 121 |
| 2018 | 29 | 128 | 71 | 158 |
| 2019 | 26 | 62 | 5 | 158 |
| 2020 | 32 | 121 | 4 | 98 |
| 2021 | 27 | 87 | 41 | 84 |
| 2022 | 30 | 74 | 13 | 138 |
| 2023 | 30 | 124 | 10 (1) | 159 |
| 2024 | 26 | 104 | 4 | 281 |
| 2025 | 26 | 122 | 8 (5) | 1,263 |
| 2026 | 24 | 126 | 43 | — |
What is it indicated for?
Visiam Dynamic Review is a software package intended for use in viewing and analyzing magnetic resonance imaging (MRI) studies. Visia TM Dynamic Review supports evaluation of dynamic MR data. Visia TM Dynamic Review automatically registers serial patient motion to minimize the impact of patient motion and visualizes different enhancement characteristics (parametric image maps). Furthermore, it performs other user-defined post-processing functions such as…
Read the full statement (177 words)
Visiam Dynamic Review is a software package intended for use in viewing and analyzing magnetic resonance imaging (MRI) studies. Visia TM Dynamic Review supports evaluation of dynamic MR data.
Visia TM Dynamic Review automatically registers serial patient motion to minimize the impact of patient motion and visualizes different enhancement characteristics (parametric image maps). Furthermore, it performs other user-defined post-processing functions such as image subtractions; multi-planar reformats and maximum intensity projections. The resulting information can be displayed in a variety of formats, including a parametric image overlaid onto the source image. Visia TM Dynamic Review can also be used to provide measurements for diameters, areas and volumes. Furthermore, Visia Dynamic Review can evaluate the uptake characteristics of segmented tissues.
Visiam Dynamic Review also displays images from a number of other imaging modalities; however, these images must not be used for primary diagnostic interpretation.
When interpreted by a skilled physician, Visia TM Dynamic Review provides information that may be useful in diagnosis. Patient management decisions should not be made based solely on the results of VisiaN Dynamic Review analysis.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K113337 · printed Nov 6, 2026
Cite this page
510(k) Report. “K113337: Visia Dynamic Review.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113337
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Page last updated Nov 3, 2026